This essential guide continues to provide invaluable information on using medications safely and effectively in the intensive care setting. Split into two sections, the first being an A-Z guide to the drugs available and concise notes on the key topics and scenarios faced on a daily basis. This section provides succinct information on each drug including uses, administration directions and adverse effects. The second section details practice guidelines on areas such as drug dosing in renal failure and haemofiltration, Parkinson's disease therapy when nil-by-mouth and insulin therapy. This new edition features an array of new drug monographs alongside thorough updates to existing monographs, guidelines and the unique IV compatibility table, which allows readers to identify compatible and non-compatible drugs combinations. Presented in a concise, compact format, this book is an invaluable resource for doctors, pharmacists, nurses, advanced clinical practitioners, and other professionals caring for critically ill patients.
- Provides critical care professionals with all the latest essential information on drug therapy in the intensive care unit in a standardised format including licensed and unlicensed dosing, right at their fingertips
- Written by an experienced critical care consultant and a pharmacist to provides a wide range of perspectives for the readership
- Featuring both new and thoroughly updated A-Z drug monographs which are quick and intuitive to access, making the drug search across the book incredibly simple
Henry G. W. Paw, York Hospital, York
Henry G. W. Paw is a consultant in Anaesthesia and Intensive Care at York Hospital, and Honorary Senior Clinical Lecturer at Hull York Medical School, York.
Rob Shulman, University College London Hospitals, London
Rob Shulman is the Lead Pharmacist in Critical Care at University College London Hospitals and is an Honorary Associate Professor in the Department of Practice and Policy at the UCL School of Pharmacy, London. He was awarded with a Faculty Fellowship of the Royal Pharmaceutical Society in 2013 and was designated a Fellow of the Royal Pharmaceutical Society in 2015.
Order On 